Make the Premium for New Drug Development Permanent: FPMAJ, PhRMA, EFPIA Japan

September 5, 2011
Chuikyo’s Expert Subcommittee on NHI Drug Pricing Affairs held hearings on the next NHI drug pricing reform for the Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ), Pharmaceutical Research and Manufacturers of America (PhRMA), and the European Federation of Pharmaceutical...read more